No Data
No Data
Oppenheimer's Best 'SMID-cap' Ideas for 2024
Blueprint Medicines(BPMC.US) Officer Sells US$1.41 Million in Common Stock
$Blueprint Medicines(BPMC.US)$ Officer Durso-Bumpus Debra sold 12,667 shares of common stock on Jul 3, 5, 2024 at an average price of $111.26 for a total value of $1.41 million. Source: Ann
Oppenheimer Adjusts Price Target on Blueprint Medicines to $125 From $114, Maintains Outperform Rating
Blueprint Medicines (BPMC) has an average outperform rating and price target range of $75 to $168, according to analysts polled by Capital IQ.Price: 112.41, Change: +0.71, Percent Change: +0.64
Blueprint Medicines Is Maintained at Outperform by Oppenheimer
Blueprint Medicines Is Maintained at Outperform by Oppenheimer
Oppenheimer Maintains Blueprint Medicines(BPMC.US) With Buy Rating, Maintains Target Price $125
Oppenheimer analyst Matthew Biegler maintains $Blueprint Medicines(BPMC.US)$ with a buy rating, and maintains the target price at $125.According to TipRanks data, the analyst has a success rate of 31.
Express News | Blueprint Medicines : Oppenheimer Raises Target Price to $125 From $114